Evidence map›Paper›PMID 32486256›Full record

ArticleNutrients2020

Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults.

Rohith N Thota, Jessica I Rosato, Tracy L Burrows, Cintia B Dias, Kylie A Abbott, Ralph N Martins, Manohar L Garg

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Rohith N ThotaNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, Australia.ORCID 0000-0002-0293-913X
Jessica I RosatoNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, Australia.
Tracy L BurrowsSchool of Health Sciences, University of Newcastle, Callaghan NSW 2308, Australia.ORCID 0000-0002-1431-7864
Cintia B DiasNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, Australia.ORCID 0000-0002-5507-3472
Kylie A AbbottNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, Australia.
Ralph N MartinsDepartment of Biomedical Sciences, Macquarie University, North Ryde NSW 2109, Australia.
Manohar L GargNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, Australia.ORCID 0000-0003-0514-0865
University of Newcastle Australia · AURiddet Institute · NZEdith Cowan University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeting kinases linked to insulin resistance (IR) and inflammation may help in reducing the risk of type 2 diabetes (T2D) and Alzheimer's disease (AD) in its early stages. This study aimed to determine whether DHA-rich fish oil supplementation reduces glycogen synthase kinase (GSK-3), which is linked to both IR and AD. Baseline and post-intervention plasma samples from 58 adults with abdominal obesity (Age: 51.7 ± 1.7 years, BMI: 31.9 ± 0.8 kg/m

Indexed as

Dietary SupplementsInsulin ResistanceAdolescentAdultAgedAlzheimer DiseaseBody Mass IndexDiabetes Mellitus, Type 2Docosahexaenoic AcidsFatty Acids, Omega-3FemaleFish OilsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansInsulinDocosahexaenoic AcidsFatty Acids, Omega-3Fish OilsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaInsulinAlzheimer’s diseasedocosahexaenoic acidglycogen synthase kinase-3insulin resistancelong-chain omega-3 polyunsaturated fatty acidsobesity

Identifiers

PMID32486256
PMCPMC7352487
OpenAlexW3031672546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.